【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Product Profiles
04.1.1 Iressa
04.1.2 Abraxane
04.1.3 Alimta
04.1.4 Gemzar
04.1.5 Xalkori
04.1.6 Avastin
04.1.7 Tarceva
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Disease Overview
07.1 Understanding the Disease
07.2 Economic Burden
07.3 Classification of Lung Cancer
07.4 Diagnosis
07.5 Small Cell Lung Cancer
07.5.1 Rate of Incidence and Prevalence
07.5.2 Staging
07.5.3 Management
07.6 Non-small Cell Lung Cancer
07.6.1 Rate of Incidence and Prevalence
07.6.2 Staging
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by Disease Type
09.1 Global Non-small Cell Lung Cancer Therapeutics Market
09.1.1 Market Size and Forecast
09.1.2 Market Segmentation by Molecule Type
09.1.3 Market Segmentation by Routes of Administration
09.2 Global Small Cell Lung Cancer Therapeutics Market
09.2.1 Market Size and Forecast
10.Market Segmentation by Molecule Type
10.1 Biologics
10.2 Small Molecules
11.Market Segmentation by Route of Administration
11.1 Oral
11.2 Parenteral
12.Geographical Segmentation
12.1 Global Non-Small-Cell Lung Cancer Market
12.2 Global Small Cell Lung Cancer Market
13.Buying Criteria
14.Market Growth Drivers
15.Drivers and their Impact
16.Market Challenges
17.Impact of Drivers and Challenges
18.Market Trends
19.Trends and their Impact
20.Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2014
20.2.1 AstraZeneca
20.2.2 Celgene
20.2.3 Eli Lilly
20.2.4 F. Hoffmann-La Roche
20.2.5 Pfizer
20.3 Other and Future Prominent Vendors
21.Pipeline Portfolio
21.1.1 Non-small Cell Lung Cancer
21.1.2 Small Cell Lung Cancer
22.Key Vendor Analysis
22.1 AstraZeneca
22.1.1 Key Facts
22.1.2 Business Description
22.1.3 Business Segmentation
22.1.4 Business Strategy
22.1.5 Revenue by Business Segmentation
22.1.6 Revenue Comparison 2011-2013
22.1.7 Sales Revenue by Geographical Segmentation
22.1.8 Key Developments
22.1.9 SWOT Analysis
22.2 Celgene
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Business Strategy
22.2.4 Business Segmentation by Revenue
22.2.5 Sales by Geography
22.2.6 Key Information
22.2.7 SWOT Analysis
22.3 Eli Lilly
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Business Segmentation by Revenue
22.3.4 Sales by Geography
22.3.5 Business Strategy
22.3.6 Key Information
22.3.7 SWOT Analysis
22.4 F. Hoffmann-La Roche Ltd.
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 Business Segmentation
22.4.4 Business Segmentation by Revenue 2012 and 2013
22.4.5 Sales by Geography
22.4.6 Business Strategy
22.4.7 Key Information
22.4.8 SWOT Analysis
22.5 Pfizer
22.5.1 Key Facts
22.5.2 Business Overview
22.5.3 Business Segmentation by Revenue 2013
22.5.4 Business Segmentation by Revenue 2012 and 2013
22.5.5 Geographical Segmentation by Revenue
22.5.6 Business Strategy
22.5.7 Key Developments
22.5.8 SWOT Analysis
23.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Incidence Data of Lung Cancer pertaining to WHO Regions
Exhibit 3: Classification of Lung Cancer Types
Exhibit 4: Diagnosis of Lung Cancer in Patients
Exhibit 5: Staging of Small Cell Lung Cancer
Exhibit 6: Stepwise Diagrammatic Representation of the Management of Small Cell Lung Cancer According to the ESMO Guidelines
Exhibit 7: Types of Non-small Cell Lung Cancer
Exhibit 8: Percentage of Gene Mutations in Non-small Cell Lung Cancer
Exhibit 9: Staging of Non-small Cell Lung Cancer
Exhibit 10: Global Lung Cancer Therapeutics Market 2014-2019 (US$ million)
Exhibit 11: Global Lung Cancer Therapeutics Market Segmentation by Disease Type
Exhibit 12: Global Lung Cancer Therapeutics Market Segmentation by Disease Type 2014
Exhibit 13: YoY Revenue Comparison of Global Non-small Cell Lung Cancer Therapeutics market and Global Small Cell Lung Cancer Therapeutics market 2014-2019 (US$ million)
Exhibit 14: Global Non-small Cell Lung Cancer Therapeutics Market 2014-2019 (US$ million)
Exhibit 15: Global Non-Small-Cell Lung Cancer Market Segmentation by Molecule Type
Exhibit 16: Global Non-Small-Cell Lung Cancer Market Segmentation by Molecule Type 2014
Exhibit 17: Global Non-Small-Cell Lung Cancer Market Segmentation by Route of Administration
Exhibit 18: Global Non-Small-Cell Lung Cancer Market Segmentation by Routes of Administration 2014
Exhibit 19: Global Small Cell Lung Cancer Therapeutics Market 2014-2019 (US$ million)
Exhibit 20: Global Lung Cancer Therapeutics Market Segmentation by Molecule Type
Exhibit 21: Global Lung Cancer Therapeutics Market Segmentation by Molecule Type 2014
Exhibit 22: Global Lung Cancer Therapeutics Market Segmentation by Route of Administration
Exhibit 23: Global Lung Cancer Therapeutics Market Segmentation by Route of Administration 2014
Exhibit 24: Global Lung Cancer Therapeutics Market by Geographical Segmentation 2014
Exhibit 25: Global Non-small Cell Lung Cancer Market by Geographical Segmentation 2014
Exhibit 26: Global Small Cell Lung Cancer Market by Geographical Segmentation 2014
Exhibit 27: Buying Criteria of Global Lung Cancer Therapeutics Market 2014
Exhibit 28: Drivers of the Global Lung Cancer Therapeutics Market
Exhibit 29: Challenges of the Global Lung Cancer Therapeutics Market
Exhibit 30: Trends of the Global Lung Cancer Therapeutics Market
Exhibit 31: Global Lung Cancer Therapeutics Market by Vendor Segmentation 2014
Exhibit 32: Global Non-Small-Cell Lung Cancer Market by Market Share Analysis 2014
Exhibit 33: Sales Comparison of Major Drugs 2010-2013 (US$ million)
Exhibit 34: Sales of Iressa 2006-2013 (US$ million)
Exhibit 35: Sales of Iressa in Western Europe 2009-2013 (US$ million)
Exhibit 36: Sales of Iressa in Established ROW 2009-2013 (US$ million)
Exhibit 37: Sales of Iressa in Emerging Markets 2009-2013 (US$ million)
Exhibit 38: Region-wise Sales of Iressa 2009-2011 (US$ million)
Exhibit 39: Sales of Abraxane 2010-2013 (US$ million)
Exhibit 40: Sales of Alimta in US 2004-2013 (US$ million)
Exhibit 41: Sales of Alimta Outside US 2004-2013 (US$ million)
Exhibit 42: Total Sales of Alimta 2004-2013 (US$ million)
Exhibit 43: Region-wise Sales of Alimta 2004-2013 (US$ million)
Exhibit 44: Sales of Gemzar in US 2003-2011 (US$ million)
Exhibit 45: Sales of Gemzar Outside US 2003-2011 (US$ million)
Exhibit 46: Total Sales of Gemzar 2003-2011 (US$ million)
Exhibit 47: Region-wise Sales Gemzar 2003-2011 (US$ million)
Exhibit 48: Sales of Avastin and Tarceva 2005-2013 (US$ million)
Exhibit 49: Sales of Avastin 2005-2013 (US$ million)
Exhibit 50: Sales of Tarceva 2005-2013 (US$ million)
Exhibit 51: Sales Forecast for Xalkori 2013-2018 (US$ million)
Exhibit 52: Phase III Pipeline Portfolio of Global Lung Cancer Therapeutics Market by Disease Type 2014
Exhibit 53: Late-stage Pipeline Molecules for Non-small Cell Lung Cancer
Exhibit 54: Late-stage Pipeline Molecules for Small Cell Lung Cancer
Exhibit 55: Study Count of Small Cell Lung Cancer Clinical Trials by Geography
Exhibit 56: Study Count of Non-small Cell Lung Cancer Clinical Trials by Geography
Exhibit 57: AstraZeneca: Business Segmentation
Exhibit 58: AstraZeneca: Revenue by Business Segmentation 2013
Exhibit 59: AstraZeneca: Revenue by Business Segmentation 2011-2013 (US$ billion)
Exhibit 60: AstraZeneca: Sales Revenue by Geographical Segmentation 2013
Exhibit 61: Celgene: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 62: Celgene: Sales by Geography 2013
Exhibit 63: Eli Lilly: Business Segmentation by Revenue 2013
Exhibit 64: Eli Lilly: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 65: Eli Lilly: Sales by Geography 2013
Exhibit 66: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
Exhibit 67: F. Hoffmann-La Roche Ltd.: Business Segmentation by Revenue 2012 and 2013
Exhibit 68: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 69: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Diagnostics Division)
Exhibit 70: Pfizer: Business Segmentation by Revenue 2013
Exhibit 71: Pfizer: Business Segmentation by Revenue 2012 and 2013
Exhibit 72: Pfizer: Geographical Segmentation by Revenue 2013
【レポート販売概要】
■ タイトル：肺がん治療薬の世界市場：非小細胞肺がん、小細胞肺がん■ 英文：Global Lung Cancer Therapeutics Market 2015-2019
■ 発行日：2014年11月26日
■ 調査会社：Technavio
■ 商品コード：IRTNTR4668
■ 調査対象地域：グローバル
- 自然食品用防腐剤の世界市場：塩、砂糖、油、蜂蜜、クエン酸、酢Natural preservatives are naturally derived additives which are used in a wide range of products, such as snacks, bakery, confectionery, meat, seafood, poultry, and others to preserve the natural characteristics of food and increase their shelf life for storage. In addition, natural food preservatives are used to avoid spoilage during transportation. The traditional natural ways of preservation in …
- ケチャップの世界市場2016-2020About the Ketchup Market Tomato ketchup, also known as catsup, is gaining popularity. The major raw materials used for making ketchup are ripe tomatoes, vinegar, sweetener, salt, spices, and other additives. Granulated cane sugar or beet sugar is generally used as a sweetener in ketchup. Other sweeteners like dextrose or liquid sugar in the form of glucose syrup can also be used. Ketchup is a good …
- 事業提携・ライセンシング・投資・M&A動向（四半期別）：Q1 2013Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2013 Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2013” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides …
- 合成紙の世界市場：製品別（BOPP、HDPE、PET）、用途別（ラベル、ラベルなし）、地域別、セグメント予測The global synthetic paper market size is expected to reach USD 1.39 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 7.1% during the forecast period. Growing demand for eco-friendly and energy-efficient products is expected to boost the product demand over the forecast period. Folding cartons and blister packaging are some of the niche …
- 医療用コネクタの世界市場予測（～2021年）The medical connectors market is projected to reach USD 2.69 Billion by 2021 from USD 1.63 Billion in 2016, at a CAGR of 10.5%. The high incidence and prevalence of chronic disorders, rise in healthcare expenditure, and growth in the home healthcare market are the major factors fueling the growth of this market. The medical connectors market is segmented based on products, application, end user, a …
- 3Dアニメーション・ソフトウェアの世界市場2015-2019About 3D animation software Computer animation is the process of creating animated images and videos with the help of computer graphics. 3D animation is a type of computer animation and includes a combination of modeling, animating, and rendering techniques. Animators model the object, animate it in a 3D environment, and then render the image for the final output. Many 3D animation software produc …
- 芳香物質の世界市場2017-2021：テルペン、ベンゼノイド、じゃこう化学品About Aroma ChemicalsAroma chemicals, also called odorants or fragrances, are natural or synthetic compounds that are characterized by their pleasant smell. These compounds are usually obtained from essential oils and the aromatic compounds. They have a molecular weight less than 300 Da and are extremely volatile and tend to vaporize. Aroma chemicals are used in the products to provide a specific …
- 粥腫切除術及び血栓摘出術用デバイスの世界市場About Atherectomy and Thrombectomy Devices Atherectomy devices are used to remove atherosclerotic plaques to clear blocked blood vessels. Atherosclerotic plaques are deposits of fats, calcium, or other substances inside the blood vessels. It is an endovascular procedure for the treatment of PAD and CAD. PVD refers to damaged or blocked peripheral blood vessels that supply blood to the arms, legs, …
- プロセスオートメーションおよびプロセス計装の世界市場2016-2020About Process Automation and Instrumentation Process automation and instrumentation help companies to optimize business outcomes by effectively controlling production processes. Automation solutions such as DCS, PLC, SCADA, and MES enable effective controlling and monitoring of production processes and reduce plant downtimes, which serve to boost productivity. Instrumentation products such as cont …
- 世界の軍用回転翼航空機の市場動向2013-2023：市場のSWOT分析This SWOT analysis of Military Rotorcraft market is a crucial resource for industry executives and anyone looking to gain a better understanding of the market. SDI's "The Global Military Rotorcraft Market 2013-2023 - SWOT Analysis: Market Profile" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. SDI strict …
- 整形外科用装具および支持具の世界市場予測The increasing number of accidents and rising number of cases of osteoarthritis, osteoporosis, and other bone disorders has led to increased research activities for treatments that help heal bone injuries. In this report, the global orthopedic braces & supports market has been analysed and segmented based on type, end-user, and region. This market has also been analyzed with an explicit focus on t …
- 物理的アイデンティティ及びアクセス管理の世界市場A physical identity & access management (PIAM) system identifies (physically), authenticates, and provides access to the authorized user. PIAM streamlines access requests and approval processes across multiple users and physical access systems. It provides authorization for accessing the systems and services through multiple environment and security domains. It enforces policies in order to protec …
- マーケティング技術の世界市場2015-2019About Global Marketing Technology Market Organizations are changing their approach toward marketing influenced by the development of new sales channels, website traffic management, and branding. Marketing is mapped now with the expectation of lead generation. With budget constraints, organizations are focusing on connecting generated leads with marketing campaigns throughout the sales process and …
- 世界の定置式発電機市場動向（2012-2016）TechNavio's analysts forecast the Global Stationary Generator market to grow at a CAGR of 6.15 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing dependency on electrical appliances and electronic devices. The Global Stationary Generator market has also been witnessing the emergence of the next-generation stationary generator. However, th …
- 世界の排煙脱硫（煙道ガス脱硫）システム及びサービス市場動向と予測（～2019）The global FGD systems and services market has witnessed a significant growth in the past few years and this stable growth is estimated to continue in the coming years. Stringent governmental regulations and increasing number of coal-fired plants will be the key influencing factors for the global FGD market. The FGD market is experiencing enormous growth which is expected to continue in the near f …
